Cellulosic copper nanoparticles and a hydrogen peroxide-based disinfectant protect Vero E6 cells against infection by viral pseudotyped particles expressing SARS-CoV-2, SARS-CoV or MERS-CoV Spike protein
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Severe acute respiratory syndrome (SARS) is a viral respiratory infection caused by human coronaviruses (HuCoV) that include SARS-CoV-2, SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV). Although their primary mode of transmission is through contaminated respiratory droplets from infected carriers, the deposition of expelled virus particles onto surface and fomites could contribute to viral transmission. Here, we use replication-deficient murine leukemia virus (MLV) pseudoviral particles expressing SARS-CoV-2, SARS-CoV, or MERS-CoV Spike (S) protein on their surface. These surrogates of native coronavirus counterparts serve as a model to analyze the S-mediated entry into target cells. Carboxymethyl cellulose (CMC) nanofibers that are combined with copper (Cu) exhibit strong antimicrobial properties. S-pseudovirions that are exposed to CMC-Cu nanoparticles (30 s) display a dramatic reduction in their ability to infect target Vero E6 cells, with ∼97% less infectivity as compared to untreated pseudovirions. In contrast, addition of the Cu chelator tetrathiomolybdate protects S- pseudovirions from CMC-Cu-mediated inactivation. When S-pseudovirions were treated with a hydrogen peroxide-based disinfectant (denoted Saber TM ) used at 1:16 dilution, their infectivity was dramatically reduced by ∼98%. However, the combined use of Saber TM and CMC-Cu is the most effective approach to restrict infectivity of SARS-CoV-2-S, SARS-CoV-S, and MERS-CoV-S pseudovirions in Vero E6 cell assays. Together, these results show that cellulosic Cu nanoparticles enhance the effectiveness of diluted Saber TM sanitizer, setting up an improved strategy to lower the risk of surface- and fomite-mediated transmission of enveloped respiratory viruses.
Article activity feed
-
SciScore for 10.1101/2022.03.22.485373: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization 47 Reverse transcription reactions were performed in a 20-µl reaction mixture that contained the specified amount of RNA transcripts produced in vitro or 1 µg of RNA extracted from either HEK-293T cells or S- pseudovirus preparations, 2 µl of random primer mix (60 µM; 25 µM oligo(dT) and 35 µM random hexamers), 2 µl 10X RT buffer, 1 µl dNTP mix (10mM) (Thermo Fisher - Invitrogen), 0.2 µl RNase inhibitor (40 U/µl), and 0.2 µl MMuLV RT (200 U/µl). Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources After electrophoresis, samples were analyzed by … SciScore for 10.1101/2022.03.22.485373: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization 47 Reverse transcription reactions were performed in a 20-µl reaction mixture that contained the specified amount of RNA transcripts produced in vitro or 1 µg of RNA extracted from either HEK-293T cells or S- pseudovirus preparations, 2 µl of random primer mix (60 µM; 25 µM oligo(dT) and 35 µM random hexamers), 2 µl 10X RT buffer, 1 µl dNTP mix (10mM) (Thermo Fisher - Invitrogen), 0.2 µl RNase inhibitor (40 U/µl), and 0.2 µl MMuLV RT (200 U/µl). Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources After electrophoresis, samples were analyzed by immunoblot assays using the following primary antibodies: monoclonal anti-p30 antibody Ab130757 (Abcam); monoclonal anti-C9 antibody Ab5417 (Abcam) (used for C9-tagged S proteins of SARS-CoV and MERS-CoV); polyclonal anti- VSV-G antibody EPR12997 (Abcam) and polyclonal anti-SARS-CoV-2 S antibody 40590-T62 (SinoBiological). anti-p30suggested: Noneanti-C9suggested: Noneanti- VSV-Gsuggested: Noneanti-SARS-CoV-2 Ssuggested: NoneExperimental Models: Cell Lines Sentences Resources Transfection of HEK-293T cells was carried out using Lipofectamine 2000 (Thermo Fisher Scientific - Invitrogen) HEK-293Tsuggested: NoneThe filtrate containing pseudoviral particles (200 µl) was inoculated onto Vero E6 cells and the cells were then incubated on a rocker for 2 h prior to addition of complete DMEM (300 µl). Vero E6suggested: NoneRecombinant DNA Sentences Resources DNA constructs: Plasmid pcDNA3.1-SARS-CoV-S contained a short coding sequence corresponding to the CD5 signal peptide (codons 1-24) that replaced the first eleven N-terminal codons in the original SARS-CoV-S sequence. pcDNA3.1-SARS-CoV-Ssuggested: NoneThe resulting PCR products were digested with HindIII and EcoRI or NotI and ApaI, and were then cloned into the HindIII-EcoRI-digested pcDNA3.1-MERS-CoV-S or NotI-ApaI-digested pcDNA3.1-SARS- CoV-2-S-Δ19 vectors. pcDNA3.1-MERS-CoV-Ssuggested: NonepcDNA3.1-SARS-suggested: NoneThe resulting plasmids were named pcDNA3.1-CD5-MERS-CoV-S and pcDNA3.1-CD5-SARS-CoV-2-S-Δ19, respectively. pcDNA3.1-CD5-MERS-CoV-Ssuggested: NoneSimilarly, the first eleven codons of SARS-CoV-2-S- Δ19 were replaced by the CD5 signal in the pcDNA3.1-CD5-SARS-CoV-2-S-Δ19 plasmid. pcDNA3.1-CD5-SARS-CoV-2-S-Δ19suggested: NoneSynthesis of Luciferase (LUC) RNA molecules for production of standard curves: Using plasmid pTG-Luc as a template, the DNA sequence encoding LUC was isolated by PCR with primers containing KpnI and BamHI sites. pTG-Lucsuggested: None36 The PCR product was cloned into the corresponding sites of pBluescript SK in which a T7 promoter sequence is found immediately next to the cloning site on the 5’ end. pBluescriptsuggested: NoneUsing BamHI-linearized pSK-Luc (5 µg per reaction), in vitro run-off transcription with T7 RNA polymerase was performed using buffer T (80 mM HEPES, pH 7.5, 20 mM MgCl2, 2 mM spermidine, 40 mM DTT and 10 mM NaCl) that was supplemented with pyrophosphatase (0.1 U/µl) as described previously. pSK-Lucsuggested: NoneSoftware and Algorithms Sentences Resources Relative luciferase units (RLU) were determined using the Glomax 20/20 luminometer (Promega) and infectivity values were analyzed as described previously 36 and plotted using GraphPad Prism 9.3.1 software. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-